There is a great deal of interest in the potential symptomatic benefits of medicinal cannabis for developmental disorders.

It is unlikely that medicinal cannabis will be used as a first-line agent for the management of pain, nausea and other specific symptoms, but it may have a complementary role within palliative care.

A man aged 79 years who was living in a residential aged care facility and had an indwelling urinary catheter was noted by the caregiver to have ‘purple urine’ for more than a week.

A woman aged 62 years had a telehealth appointment for the management of osteoporosis.

In this article, the authors describe a method for marking a lesion for excision.

Dry eye disease is often underappreciated and underdiagnosed due to the vague nature of the symptoms.

Transgender people may seek healthcare for reasons unrelated to gender, but they are often negatively impacted by structural and interpersonal discrimination in health settings.

When integrated into general practice, non-dispensing pharmacists provide clinical services within a team-based model of care to improve patient outcomes and quality use of medications.

The use of medical cannabis is an area of great interest for both general practitioners and patients and is an area of extensive ongoing research and legislative evolution.

The use of medical cannabis is an area of great interest for both general practitioners and patients and is an area of extensive ongoing research and legislative evolution.

Australia’s new national health priority of Quality Use of Medicine and Medicine Safety should stimulate all stakeholders including consumers to work together to address off-label medicine use.

Personality disorder traits should receive particular attention as they point to greater suicide risks.

This clinical challenge is based on this month’s Focus articles. To complete this activity, go to the RACGP website.

Brief behavioural therapy for insomnia distils the most effective behavioural treatment components into several brief in-person/telehealth sessions.

Guidelines on assessing and managing lipid disorders are evolving as new knowledge and treatments emerge to help health professionals and patients decide the best course of disease management.